ChartRow logo
INDV
$34.77+2.66%
as of close, Oct 20, 2026
☾ AH $34.77 +2.66%
PeersMRNALLYMDTUNHJNJTMO
Share this page

INDV financial statements

The full income statement, balance sheet, and cash-flow statement for Indivior Pharmaceuticals Inc. (INDV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 135.0M2024-09 133.0M2024-12 124.7M2025-03 124.8M2025-06 124.8M2025-09 124.9M2025-12 125.1M2026-03 121.9M2026-06 118.0M-12.6% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue1.24B+4.3%1.19B+8.7%1.09B+21.3%901M+13.9%791M
994M+3.9%957M+4.1%919M+22.7%749M+12.8%664M
Cost of revenue246M+6.5%231M+24.2%186M+17.0%159M+25.2%127M
—919M-14.3%1.07B+29.6%827M—
Research & development97.0M-9.3%107M+0.9%106M+47.2%72.0M+38.5%52.0M
Selling, general & administrative634M+3.6%612M+8.3%565M+21.2%466M—
Operating income262M+589.5%38.0M+125.0%-152M-97.4%-77.0M-136.2%213M
Interest expense45.0M+9.8%41.0M+7.9%38.0M+31.0%29.0M+7.4%27.0M
Interest & investment income22.0M-4.3%23.0M-46.5%43.0M+126.3%19.0M—
Gain (loss) on equity securities0.00+100.0%-9.00M0.000.00—
Pre-tax income239M+1095.0%20.0M+113.8%-145M-68.6%-86.0M-145.3%190M
Income tax29.0M+123.1%13.0M+168.4%-19.0M+55.8%-43.0M-186.7%-15.0M
Net income210M+2900.0%7.00M+105.6%-126M-200.0%-42.0M-120.5%205M
$1.64+3180.0%$0.05+105.4%-$0.92-206.7%-$0.30—
EPS (basic)$1.68+3260.0%$0.05+105.4%-$0.92-206.7%-$0.30—
Weighted-avg shares (basic)125M-5.3%132M-3.6%137M-1.4%139M-4.6%146M
Weighted-avg shares (diluted)128M-3.8%133M-2.9%137M-1.4%139M-8.5%152M
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
652M-21.2%827M-34.2%1.26B-0.2%1.26B-12.8%1.44B
Cash & equivalents195M-38.9%319M+0.9%316M-59.2%774M-29.8%1.10B
Short-term investments0.00-100.0%1.00M-98.9%94.0M——
Accounts receivable253M-0.4%254M+0.0%254M——
Inventory153M-8.4%167M+32.5%126M+10.5%114M+20.0%95.0M
Prepaid expenses34.0M-35.8%53.0M+1.9%52.0M——
Other current assets16.0M-23.8%21.0M———
1.20B-8.7%1.32B-25.1%1.76B-0.6%1.77B-3.4%1.83B
Property, plant & equipment144M+44.0%100M+19.0%84.0M+55.6%54.0M-6.9%58.0M
Operating lease right-of-use26.0M-33.3%39.0M-2.5%40.0M——
Goodwill2.00M+0.0%2.00M-60.0%5.00M——
Long-term investments28.0M+3.7%27.0M-34.1%41.0M——
Deferred tax assets323M+16.6%277M-3.1%286M——
Other non-current assets27.0M-30.8%39.0M+8.3%36.0M——
Total non-current assets——691M+35.5%510M+31.4%388M
914M-1.1%924M-27.9%1.28B+25.7%1.02B+26.7%804M
Accounts payable48.0M-23.8%63.0M+61.5%39.0M——
Accrued liabilities250M+15.7%216M+10.8%195M——
Short-term & current debt29.0M+61.1%18.0M+500.0%3.00M+0.0%3.00M+0.0%3.00M
Current lease liability10.0M+0.0%10.0M+11.1%9.00M——
Other current liabilities0.00-100.0%11.0M-72.5%40.0M——
1.30B-21.3%1.65B-14.9%1.94B+13.0%1.72B+5.5%1.63B
Long-term debt290M-7.9%315M+32.9%237M+0.0%237M-0.8%239M
Non-current lease liability22.0M-31.3%32.0M-5.9%34.0M——
Operating lease liability (total)32.0M-23.8%42.0M———
Other non-current liabilities21.0M+16.7%18.0M-41.9%31.0M——
-98.0M+70.9%-337M-83.2%-184M-1126.7%-15.0M-112.4%121M
Common stock62.0M+0.0%62.0M-8.8%68.0M——
Additional paid-in capital112M+24.4%90.0M+2.3%88.0M——
Retained earnings-243M+45.1%-443M-53.8%-288M——
Accumulated other comprehensive income-30.0M+16.7%-36.0M-20.0%-30.0M——
Total equity incl. non-controlling——0.00-100.0%51.0M-74.9%203M
Total liabilities & equity1.20B-8.7%1.32B-25.1%1.76B——
Common shares issued125M+0.0%125M-8.8%137M+0.7%136M-80.6%702M
Shares outstanding (cover)125M+0.3%125M-8.7%137M——
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-27.0M-175.0%36.0M+112.0%-300M-7400.0%-4.00M-101.1%353M
Depreciation & amortization10.0M-37.5%16.0M+6.7%15.0M-6.3%16.0M+33.3%12.0M
Intangible amortization——10.0M+100.0%5.00M-16.7%6.00M
Share-based compensation26.0M+8.3%24.0M+14.3%21.0M+31.3%16.0M—
Deferred income taxes-46.0M-757.1%7.00M+110.9%-64.0M+38.5%-104M—
Change in receivables-3.00M-400.0%1.00M-97.0%33.0M+57.1%21.0M—
Change in inventory-18.0M-141.9%43.0M+616.7%6.00M-80.0%30.0M—
-66.0M-195.7%69.0M+172.6%-95.0M+57.2%-222M—
Capital expenditure66.0M+127.6%29.0M+262.5%8.00M+60.0%5.00M+25.0%4.00M
Free cash flow-93.0M-1428.6%7.00M+102.3%-308M-3322.2%-9.00M-102.6%349M
Acquisitions0.000.00-100.0%129M0.000.00
Other investing activities0.000.00+100.0%-3.00M-200.0%-1.00M—
-30.0M+70.6%-102M-59.4%-64.0M+36.6%-101M—
Long-term debt issued0.00-100.0%332M0.000.00-100.0%250M
Long-term debt repaid17.0M-92.9%240M+1900.0%12.0M+300.0%3.00M-98.7%236M
Common stock issued2.00M-33.3%3.00M+0.0%3.00M+50.0%2.00M+100.0%1.00M
Common stock repurchased11.0M-93.6%173M+424.2%33.0M-63.3%90.0M0.00
Dividends paid0.000.000.000.000.00
Other financing activities—-2.00M0.000.00—
FX effect on cash—0.00-100.0%1.00M+200.0%-1.00M—
Interest paid34.0M+21.4%28.0M+7.7%26.0M+44.4%18.0M—
Income taxes paid38.0M-17.4%46.0M+43.8%32.0M-43.9%57.0M—
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap4.49B+189.6%1.55B-27.0%2.12B-35.8%3.30B+530.4%524M
P/E21.4×-90.3%221.4×—16.1×+530.4%2.6×
P/S3.6×+177.7%1.3×-44.6%2.4×-43.6%4.2×+530.4%0.7×
P/B———27.3×+530.4%4.3×
P/FCF—221.4×—9.5×+530.4%1.5×
Earnings yield4.7%+935.9%0.45%—6.2%-84.1%39.1%
FCF yield—0.45%—10.6%-84.1%66.6%
Source filing10-K10-K20-F10-K10-K

About this data

Source: INDV’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all INDV filings on SEC EDGAR → Not investment advice.